1
|
Li F, Liao Y, Lei C, Zhou J, Li Y, Shi Q. Risk factors for postpartum depression in pregnant women with allergic rhinitis: a retrospective study. BMC Psychiatry 2025; 25:276. [PMID: 40133909 PMCID: PMC11938620 DOI: 10.1186/s12888-025-06702-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/28/2024] [Accepted: 03/11/2025] [Indexed: 03/27/2025] Open
Abstract
OBJECTIVE Allergic rhinitis can cause symptoms to worsen after pregnancy and may cause problems such as postpartum depression. The goal of this study was to investigate the factors that influence postpartum depression in pregnant women with allergic rhinitis (AR). METHODS We conducted a retrospective cohort study that included women with AR (based on self-reports) between June 2015 to June 2019 in Harvard University Partners Healthcare Systems (PARTNERS) in the USA. The study group was divided into postpartum depression and non-postpartum depression. Routine clinical and laboratory information was collected. Univariate and least absolute shrinkage and selection operator (LASSO, employed for predictor selection) regression analysis was used to study associations between AR during pollen seasons and adverse outcomes. Additionally, the receiver operating characteristic (ROC) curve evaluates discriminative ability by the area under the ROC curve (AUC). The calibration curve (DCA) was conducted to determine the clinical utility and benefit of the nomogram. RESULTS A total of 216 pregnant women with AR participated in this study. Univariate analysis showed that 7 indicators were significantly different (P < 0.05). LASSO and multivariable regression identified four predictors to construct a nomogram for PPD in pregnant women with AR, the four selected risk predictors are as follows: pollen season pregnancy (OR = 1.514, 95%CI: 0.771-2.973), history of preterm birth (OR = 2.723, 95%CI: 1.157-6.406), number of pregnancies (OR = 2.104, 95%CI: 1.356-3.267), anti-allergy medication during pregnancy (OR = 2.975, 95%CI: 1.521-5.819). The nomogram displayed good discrimination, with AUC of 0.732 (95% CI: 0.657-0.808). The risk of postpartum depression increased with the increasing risk score of predictive nomogram. The calibration curve and DCA present optimal predictive power. CONCLUSIONS We highlighted the comorbidity of AR and postpartum depression, and suggested that a multidisciplinary consideration between allergists and obstetricians or midwives is needed to ensure that pregnant women consult experts to reduce AR symptoms. TRIAL REGISTRATION NUMBER 2018P002646.
Collapse
Affiliation(s)
- Fan Li
- Department of Otolaryngology-Head and Neck Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China
- School of Public Health, Chongqing Medical University, Chongqing, China
| | - Yuan Liao
- Department of Obstetrics and Gynecology, Chongqing General Hospital, Chongqing University, Chongqing, China
| | - Cheng Lei
- School of Public Health, Chongqing Medical University, Chongqing, China
| | - Jie Zhou
- Department of Anesthesiology, Perioperative and Pain Medicine, Brigham & Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA
| | - Yannan Li
- Department of quality management section, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
- Department of quality management section, Chongqing Health Center for Women and Children, Chongqing, China.
| | - Qiuling Shi
- School of Public Health, Chongqing Medical University, Chongqing, China.
| |
Collapse
|
2
|
Tuniyazi M, Li S, Hu X, Fu Y, Zhang N. The Role of Early Life Microbiota Composition in the Development of Allergic Diseases. Microorganisms 2022; 10:1190. [PMID: 35744708 PMCID: PMC9227185 DOI: 10.3390/microorganisms10061190] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2022] [Revised: 06/02/2022] [Accepted: 06/07/2022] [Indexed: 11/28/2022] Open
Abstract
Allergic diseases are becoming a major healthcare issue in many developed nations, where living environment and lifestyle are most predominantly distinct. Such differences include urbanized, industrialized living environments, overused hygiene products, antibiotics, stationary lifestyle, and fast-food-based diets, which tend to reduce microbial diversity and lead to impaired immune protection, which further increase the development of allergic diseases. At the same time, studies have also shown that modulating a microbiocidal community can ameliorate allergic symptoms. Therefore, in this paper, we aimed to review recent findings on the potential role of human microbiota in the gastrointestinal tract, surface of skin, and respiratory tract in the development of allergic diseases. Furthermore, we addressed a potential therapeutic or even preventive strategy for such allergic diseases by modulating human microbial composition.
Collapse
Affiliation(s)
| | | | | | - Yunhe Fu
- Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun 130062, China; (M.T.); (S.L.); (X.H.)
| | - Naisheng Zhang
- Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun 130062, China; (M.T.); (S.L.); (X.H.)
| |
Collapse
|
3
|
Olsson Mägi CA, Wik Despriee Å, Småstuen MC, Almqvist C, Bahram F, Bakkeheim E, Bjerg A, Glavin K, Granum B, Haugen G, Hedlin G, Jonassen CM, Lødrup Carlsen KC, Rehbinder EM, Rolfsjord LB, Staff AC, Skjerven HO, Vettukattil R, Nordlund B, Söderhäll C. Maternal Stress, Early Life Factors and Infant Salivary Cortisol Levels. CHILDREN 2022; 9:children9050623. [PMID: 35626800 PMCID: PMC9139396 DOI: 10.3390/children9050623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Revised: 04/09/2022] [Accepted: 04/20/2022] [Indexed: 11/30/2022]
Abstract
Background: Salivary cortisol (SC), a commonly used biomarker for stress, may be disrupted by negative events in pregnancy, at birth and in infancy. We aimed to explore if maternal perceived stress (PSS) in or after pregnancy and SC levels in pregnancy were associated with SC in early infancy, and, secondly, to identify early life factors associated with infants’ SC levels (iSC). Methods: At 3 months of age, SC was analyzed in 1057 infants participating in a Nordic prospective mother-child birth cohort study. Maternal PSS was available from questionnaires at 18- and 34-week gestational age (GA) and 3-month post-partum, and SC was analyzed at 18-week GA. Early life factors included sociodemographic and infant feeding from questionnaires, and birth data from medical charts. Associations to iSC were analyzed by Spearman correlation and multinomial logistic regression analyses. Results: In this exploratory study neither PSS at any time point nor maternal SC (mSC) were associated with iSC. Higher birth weight was associated with higher levels of iSC, while inverse associations were observed in infants to a mother not living with a partner and mixed bottle/breastfeeding. Conclusions: Maternal stress was not associated with iSC levels, while birth weight, single motherhood and infant feeding may influence iSC levels.
Collapse
Affiliation(s)
- Caroline-Aleksi Olsson Mägi
- Department of Women’s and Children’s Health, Karolinska Institutet, SE-171 77 Stockholm, Sweden; (A.B.); (G.H.); (B.N.); (C.S.)
- Astrid Lindgren Children’s Hospital, Karolinska University Hospital, SE-171 64 Stockholm, Sweden;
- Correspondence:
| | - Åshild Wik Despriee
- Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway; (Å.W.D.); (G.H.); (K.C.L.C.); (A.C.S.); (H.O.S.); (R.V.)
- Faculty of Health, VID Specialized University, NO-0424 Oslo, Norway; (M.C.S.); (K.G.)
| | | | - Catarina Almqvist
- Astrid Lindgren Children’s Hospital, Karolinska University Hospital, SE-171 64 Stockholm, Sweden;
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Fuad Bahram
- Research Centre, Stockholm South General Hospital, SE-118 83 Stockholm, Sweden;
| | - Egil Bakkeheim
- Division of Paediatric and Adolescent Medicine, Oslo University Hospital, NO-0424 Oslo, Norway; (E.B.); (L.-B.R.)
| | - Anders Bjerg
- Department of Women’s and Children’s Health, Karolinska Institutet, SE-171 77 Stockholm, Sweden; (A.B.); (G.H.); (B.N.); (C.S.)
- Martina Children’s Hospital, SE-114 86 Stockholm, Sweden
| | - Kari Glavin
- Faculty of Health, VID Specialized University, NO-0424 Oslo, Norway; (M.C.S.); (K.G.)
| | - Berit Granum
- Department of Chemical Toxicology, Norwegian Institute of Public Health, NO-0213 Oslo, Norway;
| | - Guttorm Haugen
- Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway; (Å.W.D.); (G.H.); (K.C.L.C.); (A.C.S.); (H.O.S.); (R.V.)
- Division of Obstetrics and Gynaecology, Oslo University Hospital, NO-0424 Oslo, Norway
| | - Gunilla Hedlin
- Department of Women’s and Children’s Health, Karolinska Institutet, SE-171 77 Stockholm, Sweden; (A.B.); (G.H.); (B.N.); (C.S.)
- Astrid Lindgren Children’s Hospital, Karolinska University Hospital, SE-171 64 Stockholm, Sweden;
| | - Christine Monceyron Jonassen
- Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, NO-1430 Ås, Norway;
- Genetic Unit, Centre for Laboratory Medicine, Østfold Hospital Trust, NO-1714 Kalnes, Norway
| | - Karin C. Lødrup Carlsen
- Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway; (Å.W.D.); (G.H.); (K.C.L.C.); (A.C.S.); (H.O.S.); (R.V.)
- Division of Paediatric and Adolescent Medicine, Oslo University Hospital, NO-0424 Oslo, Norway; (E.B.); (L.-B.R.)
| | - Eva Maria Rehbinder
- Department of Dermatology and Vaenerology, Oslo University Hospital, NO-0424 Oslo, Norway;
| | - Leif-Bjarte Rolfsjord
- Division of Paediatric and Adolescent Medicine, Oslo University Hospital, NO-0424 Oslo, Norway; (E.B.); (L.-B.R.)
- Department of Paediatric and Adolescent Medicine Elverum, Innlandet Hospital Trust, NO-2381 Brumunddal, Norway
| | - Anne Cathrine Staff
- Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway; (Å.W.D.); (G.H.); (K.C.L.C.); (A.C.S.); (H.O.S.); (R.V.)
- Division of Obstetrics and Gynaecology, Oslo University Hospital, NO-0424 Oslo, Norway
| | - Håvard Ove Skjerven
- Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway; (Å.W.D.); (G.H.); (K.C.L.C.); (A.C.S.); (H.O.S.); (R.V.)
- Division of Paediatric and Adolescent Medicine, Oslo University Hospital, NO-0424 Oslo, Norway; (E.B.); (L.-B.R.)
| | - Riyas Vettukattil
- Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway; (Å.W.D.); (G.H.); (K.C.L.C.); (A.C.S.); (H.O.S.); (R.V.)
- Division of Paediatric and Adolescent Medicine, Oslo University Hospital, NO-0424 Oslo, Norway; (E.B.); (L.-B.R.)
| | - Björn Nordlund
- Department of Women’s and Children’s Health, Karolinska Institutet, SE-171 77 Stockholm, Sweden; (A.B.); (G.H.); (B.N.); (C.S.)
- Astrid Lindgren Children’s Hospital, Karolinska University Hospital, SE-171 64 Stockholm, Sweden;
| | - Cilla Söderhäll
- Department of Women’s and Children’s Health, Karolinska Institutet, SE-171 77 Stockholm, Sweden; (A.B.); (G.H.); (B.N.); (C.S.)
- Astrid Lindgren Children’s Hospital, Karolinska University Hospital, SE-171 64 Stockholm, Sweden;
| |
Collapse
|
4
|
General Stress Among Young Adults with Asthma During the COVID-19 Pandemic. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE 2022; 10:108-115. [PMID: 34785389 PMCID: PMC8590620 DOI: 10.1016/j.jaip.2021.10.069] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Revised: 10/12/2021] [Accepted: 10/29/2021] [Indexed: 11/22/2022]
Abstract
Background The coronavirus disease 2019 (COVID-19) pandemic has profoundly affected the lives of the global population. Objective To explore anxiety and stress in relation to COVID-19 among young adults, and the potential influence of asthma and allergic rhinitis. Methods This cross-sectional study included 1644 participants from the population-based birth cohort BAMSE (Swedish abbreviation for Children, Allergy, Milieu, Stockholm, Epidemiology), participating in a follow-up at age 24 years and a COVID-19 follow-up conducted in August-November 2020 (mean age, 25.3 years). Anxiety and concern related to COVID-19 were analyzed as general anxiety, concern of own health and health of family members, and contact with online health care providers due to concern about COVID-19. Stress was measured with the perceived stress scale. Results Around half the participants reported increased anxiety due to COVID-19, and this was more common among females (57.0%, compared with 42.6% in males; P < .001). Young adults with asthma reported more concern about their own health (adjusted odds ratio, 1.50; 95% CI, 1.12-2.02) and perceived stress (adjusted regression coefficient [adjusted β], 1.49; 95% CI, 0.52-2.45) compared with peers without asthma, and this was more pronounced among females and those with uncontrolled asthma. Symptoms of allergic rhinitis were not associated with increased concern or anxiety in relation to COVID-19. Conclusions Young adults with asthma experience more COVID-19–related health concerns, compared with those without asthma, especially females and participants with uncontrolled asthma This needs to be considered in the care of young people with asthma.
Collapse
|